MicroRNA 3171 (MIR3171)

MicroRNA 3171 (MIR3171, hsa-mir-3171) is classified as a microRNA, a type of small, single-stranded, non-coding RNA about 21–23 nucleotides in length that is involved in post-transcriptional regulation of gene expression by binding to complementary sequences in messenger RNAs (mRNAs), leading to their silencing through destabilization, cleavage, or translational inhibition[1][4][5]. MicroRNAs play key roles in gene regulatory networks across many biological processes and are essential for fine-tuning and buffering gene expression, but individual microRNAs often have highly redundant or context-dependent functions[2][5]. While some miRNAs are implicated as disease biomarkers or therapeutic targets, there is currently no evidence or established literature suggesting that MIR3171 is itself a therapeutic target, receptor, enzyme, or directly druggable molecule; nor is there evidence for specific roles in disease, drug interactions, or mechanisms of drug action for MIR3171. In general, the field acknowledges the vast number of annotated miRNAs, but only a fraction have well-validated, high-confidence functional data[5]. Note on correctness: Although "microRNA 3171" (MIR3171) appears in miRNA annotation databases as a locus, there is a significant lack of curated or experimentally validated information regarding its biological role, disease relevance, or therapeutic targeting. Most references and reviews on microRNA biology discuss general properties of this molecular class but do not describe MIR3171 specifically. Thus, treating MIR3171 as a drug target, receptor, enzyme, or similar entity is not currently supported. This entry is better considered a non-coding RNA locus of unknown or unproven function, and its inclusion as a target would be incorrect at present[5].

Other names

hsa-mir-3171MIR3171